Virus and antibody dynamics in acute west nile virus infection.
暂无分享,去创建一个
R. Lanciotti | H. Kamel | S. Kleinman | M. Busch | H. Prince | J. Matud | L. Tobler | D. Wright | J. Linnen | P. Norris | S. Caglioti | I. Walsh | M. Busch
[1] Marion C Lanteri,et al. Interferon and Interferon-Induced Chemokine Expression Is Associated with Control of Acute Viremia in West Nile Virus-Infected Blood Donors , 2008, The Journal of infectious diseases.
[2] Rachel E. Owen,et al. Comprehensive analysis of west nile virus-specific T cell responses in humans. , 2008, The Journal of infectious diseases.
[3] J. L. Knight,et al. Performance evaluation of the PROCLEIX® West Nile virus assay on semi‐automated and automated systems , 2007, Journal of medical virology.
[4] I. Hewlett,et al. West Nile virus adheres to human red blood cells in whole blood. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] M. Diamond,et al. Cell-Specific IRF-3 Responses Protect against West Nile Virus Infection by Interferon-Dependent and -Independent Mechanisms , 2007, PLoS pathogens.
[6] P. Mason,et al. Early Production of Type I Interferon during West Nile Virus Infection: Role for Lymphoid Tissues in IRF3-Independent Interferon Production , 2007, Journal of Virology.
[7] Theresa L. Smith,et al. Transfusion‐associated transmission of West Nile virus, United States 2003 through 2005 , 2006, Transfusion.
[8] M. Diamond,et al. Gamma Interferon Plays a Crucial Early Antiviral Role in Protection against West Nile Virus Infection , 2006, Journal of Virology.
[9] J. Fox,et al. Nucleic acid testing for west nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients. , 2006, The Journal of infectious diseases.
[10] B. Custer,et al. West Nile Virus Infections Projected from Blood Donor Screening Data, United States, 2003 , 2006, Emerging infectious diseases.
[11] S. Stramer,et al. Self‐reported symptoms associated with West Nile virus infection in RNA‐positive blood donors , 2006, Transfusion.
[12] B. Custer,et al. The Cost-Effectiveness of Screening the U.S. Blood Supply for West Nile Virus , 2005, Annals of Internal Medicine.
[13] M. Busch,et al. Development and Persistence of West Nile Virus-Specific Immunoglobulin M (IgM), IgA, and IgG in Viremic Blood Donors , 2005, Journal of Clinical Microbiology.
[14] Peter Tomasulo,et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. , 2005, The New England journal of medicine.
[15] G. Foster,et al. West Nile Virus Among Blood Donors in the United States, 2003 and 2004 , 2005, The New England journal of medicine.
[16] S. Glynn,et al. The 2003 West Nile virus United States epidemic: the America's Blood Centers experience , 2005, Transfusion.
[17] M. Drebot,et al. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003 , 2005, Transfusion.
[18] E. Hayes,et al. Westward ho?--The spread of West Nile virus. , 2004, The New England journal of medicine.
[19] P. Tomasulo,et al. Triggers for switching from minipool testing by nucleic acid technology to individual‐donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making , 2004, Transfusion.
[20] Roderick C. Jones,et al. Clinical Characteristics and Functional Outcomes of West Nile Fever , 2004, Annals of Internal Medicine.
[21] Sally Caglioti,et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. , 2004, The New England journal of medicine.
[22] W. Fawzi,et al. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. , 2004, The Journal of infectious diseases.
[23] Shin Ta Liu,et al. SAS® Survival Analysis Techniques for Medical Research , 2004, Technometrics.
[24] A. Bagić,et al. West Nile Virus: Pathogenesis and Therapeutic Options , 2004, Annals of Internal Medicine.
[25] D. Descamps,et al. Estimating and Comparing Reduction in HIV-1 RNA in Clinical Trials Using Methods for Interval Censored Data , 2004, Journal of acquired immune deficiency syndromes.
[26] R. Dodd. Emerging infections, transfusion safety, and epidemiology. , 2003, The New England journal of medicine.
[27] R. Lanciotti,et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. , 2003, The New England journal of medicine.
[28] W. Hogrefe,et al. Detection of West Nile Virus (WNV)-Specific Immunoglobulin M in a Reference Laboratory Setting during the 2002 WNV Season in the United States , 2003, Clinical Diagnostic Laboratory Immunology.
[29] Denise A. Martin,et al. Persistence of Virus-Reactive Serum Immunoglobulin M Antibody in Confirmed West Nile Virus Encephalitis Cases , 2003, Emerging infectious diseases.
[30] L. Petersen,et al. West Nile Virus: A Primer for the Clinician , 2002, Annals of Internal Medicine.
[31] Denise A. Martin,et al. Use of Immunoglobulin M Cross-Reactions in Differential Diagnosis of Human Flaviviral Encephalitis Infections in the United States , 2002, Clinical and Vaccine Immunology.
[32] V. Carey,et al. Mixed-Effects Models in S and S-Plus , 2001 .
[33] A. Hannigan,et al. A Re-analysis of a Caries Clinical Trial by Survival Analysis , 2001, Journal of dental research.
[34] D. Bates,et al. Mixed-Effects Models in S and S-PLUS , 2001 .
[35] J C Lindsey,et al. Tutorial in biostatistics methods for interval-censored data. , 1998, Statistics in medicine.
[36] T. Mazzulli,et al. [Diagnosis of viral infections]. , 1976, Wiener medizinische Wochenschrift.
[37] B. Turnbull. The Empirical Distribution Function with Arbitrarily Grouped, Censored, and Truncated Data , 1976 .
[38] T. Mazzulli,et al. Diagnosis of Viral Infections , 2009 .
[39] J. Stockman. The Cost-Effectiveness of Screening the US Blood Supply for West Nile Virus , 2007 .
[40] Transfusion-associated transmission of West Nile virus--Arizona, 2004. , 2004, MMWR. Morbidity and mortality weekly report.
[41] M. Harlow. Food and Drug Administration Center for Biologics Evaluation and Research , 2003 .
[42] S. Ruță,et al. Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile Virus infection. , 2000, Journal of clinical microbiology.
[43] C. Southam,et al. Induced virus infections in man by the Egypt isolates of West Nile virus. , 1954, The American journal of tropical medicine and hygiene.
[44] Fitting linear mixed-effects models , 2022 .